
Number of publications published per year by Aldrighetti, Luca. (Source : PubMed)

Distribution of publications types for Aldrighetti, Luca. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
The cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG) regimen in advanced biliary tract adenocarcinoma.
Cancer
2010;116;9
Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients.
J. Am. Coll. Surg.
2010;210;5

Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis.
J. Gastrointest. Surg.
2009;13;12

Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion.
Annals of surgical oncology
2009;16;5
IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes.
Blood
2009;113;5
Comparative performances of staging systems for early hepatocellular carcinoma.
HPB (Oxford)
2009;11;5

The current role of laparoscopic liver resection for the treatment of liver tumors.
Nature clinical practice. Gastroenterology & hepatology
2008;5;11


Surgical management of early-stage hepatocellular carcinoma: resection or transplantation?
J. Gastrointest. Surg.
2008;12;10
Laparoscopic liver resection without portal clamping: a prospective evaluation.
Surg Endosc
2008;22;10

Effects of adjuvant therapy on the outcomes of surgical management of extrahepatic biliary atresia.
Hepatology
2008;48;1
[ See timeline ] [ See all publications ]
means that Aldrighetti, Luca has 13 papers cited a least 13 times - methodology
Department of Surgery-Liver Unit, Scientific Institute San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.